Donohue syndrome is of several diseases associated with defects in the insulin receptor, INSR; it is one of a group of related conditions described as inherited severe insulin resistance syndromes.
Constructs carrying mutations in the fly ortholog of INSR, Dmel\InR, analogous to a human variant implicated in Donohue syndrome have been constructed and made available. Variant(s) implicated in human disease created (as analogous mutation in fly gene): K414P in the fly InR gene (corresponds to R113P in the human INSR gene).
See the human disease model report for insulin resistance syndromes, INSR-related (FBhh0000168) for information on experimental results using Drosophila models of this and related diseases.
[updated Mar. 2020 by FlyBase; FBrf0222196]
[DONOHUE SYNDROME](https://omim.org/entry/246200)
[INSULIN RECEPTOR; INSR](https://omim.org/entry/147670)
Severe insulin resistance underlies the varied signs and symptoms of Donohue syndrome. Individuals with Donohue syndrome are unusually small starting before birth, and affected infants experience failure to thrive. Donohue syndrome is one of a group of related conditions described as inherited severe insulin resistance syndromes. Donohue syndrome represents the most severe end of the spectrum; children with this condition do not survive beyond age 2. [from Genetics Home Reference, Donohue syndrome; 2016.02.04]
See general description of diabetes mellitus, noninsulin-dependent (FBhh0000153).
Donohue syndrome is caused by homozygous or compound heterozygous mutation in the insulin receptor gene (INSR). [from MIM:246200; 2016.02.04]